Silence Therapeutics Plc ADR (SLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 422 | 34 | 159 | 224 | 142 |
| Cost of Goods | 11 | 12 | 64 | 85 | 54 |
| Gross Profit | 411 | 22 | 95 | 139 | 88 |
| Operating Expenses | 16,159 | 12,495 | 26,403 | 24,187 | 28,551 |
| Operating Income | -15,737 | -12,461 | -26,244 | -23,963 | -28,409 |
| Other Income | 780 | 691 | 5,287 | -3,381 | -121 |
| Pre-tax Income | -14,957 | -11,770 | -20,957 | -27,344 | -28,530 |
| Income Tax | N/A | N/A | 1 | 10 | N/A |
| Net Income Continuous | -14,957 | -11,770 | -20,958 | -27,354 | -28,530 |
| Net Income | $-14,957 | $-11,770 | $-20,958 | $-27,354 | $-28,530 |
| EPS Basic Total Ops | -0.33 | -0.26 | -0.45 | -0.57 | -0.60 |
| EPS Basic Continuous Ops | -0.32 | -0.25 | -0.44 | -0.58 | -0.60 |
| EPS Diluted Total Ops | -0.33 | -0.26 | -0.45 | -0.57 | -0.60 |
| EPS Diluted Continuous Ops | -0.32 | -0.25 | -0.44 | -0.58 | -0.60 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.25 | -0.45 | -0.54 | -0.60 |
| EBITDA(a) | $-15,631 | $-12,348 | $-26,088 | $-23,815 | $-28,271 |